NetworkNewsBreaks – Delic Holdings Corp. (CSE: D
Post# of 135
(Total Views: 180)
Posted On: 02/09/2022 2:48:08 PM
NetworkNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Committed to Bringing Science-Backed Health Benefits to All, Reframing Psychedelic Conversation
Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, has sought to capitalize on the ongoing transformation within the mental health sector. The company is positioning itself as the United States’ leading psychedelic wellness platform committed to bringing science-backed benefits to all and reframing the psychedelic conversation. This comes as Representative Earl Blumenauer recently circulated an open letter to his colleagues in Congress, urging them to join him in petitioning the DEA to permit terminally ill patients to use psilocybin as part of their treatment without fear of being federally prosecuted. Although the DEA has remained steadfast in its stance to continue denying patients access to psilocybin, the tide seems to be shifting. “Scientific research within the psychedelic sector has increasingly uncovered the substance’s potential to relieve a broad array of psychological maladies, including depression, anxiety and addiction,” explains a recent article. “Founded in 2018, Delic Corp. has sought to transform itself into a champion of the psychedelic wellness sector, including psilocybin, through its myriad business interests.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, has sought to capitalize on the ongoing transformation within the mental health sector. The company is positioning itself as the United States’ leading psychedelic wellness platform committed to bringing science-backed benefits to all and reframing the psychedelic conversation. This comes as Representative Earl Blumenauer recently circulated an open letter to his colleagues in Congress, urging them to join him in petitioning the DEA to permit terminally ill patients to use psilocybin as part of their treatment without fear of being federally prosecuted. Although the DEA has remained steadfast in its stance to continue denying patients access to psilocybin, the tide seems to be shifting. “Scientific research within the psychedelic sector has increasingly uncovered the substance’s potential to relieve a broad array of psychological maladies, including depression, anxiety and addiction,” explains a recent article. “Founded in 2018, Delic Corp. has sought to transform itself into a champion of the psychedelic wellness sector, including psilocybin, through its myriad business interests.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)